FDA approves new treatment for a rare genetic disorder, Fabry disease
The U.S. Food and Drug Administration approved GalafoldĀ (migalastat), the first oral medication for the treatment of adults with Fabry disease. The drug is indicated for adults with Fabry disease who...
Read More